Abstract
HUMAN plasminogen activator inhibitor-1 (PAI-1)1,2 is the fast-acting inhibitor of tissue plasminogen activator and urokinase3 and is a member of the serpin family of protease inhibitors4. Serpins normally form complexes with their target proteases that dissociate very slowly as cleaved species and then fold into a highly stable inactive state5 in which the residues that flank the scissile bond (P1 and P1'; ref. 6) are separated by about 70 Å (refs 7–9). PAI-1 also spontaneously folds into a stable10 inactive state without cleavage; this state is termed 'latent' because inhibitory activity can be restored through denaturation and renaturation2,10. Here we report the structure of intact latent PAI-1 determined by single-crystal X-ray diffraction to 2.6 Å resolution. The three-dimensional structure reveals that residues on the N-terminal side of the primary recognition site are inserted as a central strand of the largest βsheet, in positions similar to the corresponding residues in the cleaved form of the serpin α1proteinase inhibitor (α1-PI)7. Residues C-terminal to the recognition site occupy positions on the surface of the molecule distinct from those of the corresponding residues in cleaved serpins7–9 or in the intact inactive serpin homologue, ovalbumin11, and its cleavage product, plakal-bumin12. The structure of latent PAI-1 is similar to one formed after cleavage in other serpins, and the stability of both latent PAI-1 and cleaved serpins may be derived from the same structural features13,14.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ny, T., Sawdey, M., Lawrence, D., Millan, J. L. & Loskutoff, D. J. Proc. natn. Acad. Sci. U.S.A. 83, 6776–6780 (1986).
Hekman, C. M. & Loskutoff, D. J. J. biol. Chem. 260, 11581–11587 (1985).
Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A. & Stacey, S. N. Molec. cell. Endocr. 68, 1–19 (1990).
Huber, R. & Carrell, R. W. Biochemistry 28, 8951–8966 (1989).
Bruch, M., Weiss, V. & Engel, J. J. biol. Chem. 263, 16626–16630 (1988).
Schechter, I. & Berger, A. Biochem. biophys. Res. Commun. 27, 157–162 (1967).
Loebermann, H., Tokuoka, R., Deisenhofer, J. & Huber, R. J. molec. Biol. 177, 531–556 (1984).
Baumann, U. et al. J. molec. Biol. 218, 595–606 (1991).
Mourey, L. et al. Biochimie 72, 599–608 (1990).
Katagiri, K., Okada, K., Hattori, H. & Yano, M. Eur. J. Biochem. 176, 81–87 (1988).
Stein, P. E. et al. Nature 347, 99–102 (1990).
Wright, H. T., Qian, H. X. & Huber, R. J. molec. Biol. 213, 513–528 (1990).
Munch, M., Heegaard, C., Jensen, P. H. & Andreasen, P. A. EMBO J. (in the press).
Carrell, R. W., Evans, D. L. & Stein, P. E. Nature 353, 576–578 (1991).
Papamokos, E. et al. J. molec. Biol. 158, 515–537 (1982).
Madison, E. L., Goldsmith, E. J., Gerard, R., Gething, M. J. & Sambrook, J. F. Nature 339, 721–723 (1989).
Madison, E. L. et al. Proc. natn. Acad. Sci. U.S.A. 87, 3530–3533 (1990).
Madison, E. L., Goldsmith, E. J., Gething, M. J., Sambrook, J. F. & Gerard, R. D. J. biol. Chem. 265, 21423–21426 (1990).
Kress, L. F., Kurecki, T., Chan, S. K. & Laskowski, M. J. biol. Chem. 254, 5317–5320 (1979).
Schulze, A. J. et al. Eur. J. Biochem. 194, 51–56 (1990).
Skriver, K. et al. J. biol. Chem. 266, 9216–9221 (1991).
Lawrence, D. A., Strandberg, L., Ericson, J. & Ny, T. J. biol. Chem. 265, 20293–20301 (1990).
Wiman, B., Almquist, Å., Sigurdardottir, O. & Lindahl, T. FEBS Lett. 242, 125–128 (1988).
Carrell, R. W. & Owen, M. C. Nature 317, 730–732 (1985).
Jones, T. A. & Kjeldgaard, M. O. Version 5.4 (Dept Molec. Biol., Univ. Uppsala, Sweden, 1991).
Franke, A. E. et al. Biochim. biophys. Acta 1037, 16–23 (1990).
Goldsmith, E. J. et al. Proteins 9, 225–227 (1991).
Howard, A. J., Nielsen, C. & Xuong, N.-H. Meth. Enzym. 114a, 452–472 (1985).
Crowther, R. A. Acta crystallogr. B25, 2571–2580 (1969).
Crowther, R. A. & Blow, D. M. Acta crystallogr. 23, 544–548 (1967).
Fitzgerald, P. F. J. appl. Crystallogr. 21, 273–278 (1988).
Brünger, A. T., Kuriyan, J. & Karplus, M. Science 235, 458–460 (1987).
Carson, M. & Bugg, C. E. J. molec. Graph. 4, 121–122 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mottonen, J., Strand, A., Symersky, J. et al. Structural basis of latency in plasminogen activator inhibitor-1. Nature 355, 270–273 (1992). https://doi.org/10.1038/355270a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/355270a0
This article is cited by
-
Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection
Scientific Reports (2023)
-
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system
Thrombosis Journal (2022)
-
Naa10p promotes cell invasiveness of esophageal cancer by coordinating the c-Myc and PAI1 regulatory axis
Cell Death & Disease (2022)
-
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape
Scientific Reports (2021)
-
The Last Secret of Protein Folding: The Real Relationship Between Long-Range Interactions and Local Structures
The Protein Journal (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.